Both these cases indicate that TMB and PDL-1 provide only a piece of the information regarding ICI response prediction, whereas, the tumor alterations detected by NGS analysis could strengthen or weaken the probability of treatment effectiveness. This evidence concerns the gene CD274 and neoplasm.